Evolus Inc (EOLS)
12.84
+0.24
(+1.87%)
USD |
NASDAQ |
Nov 25, 13:14
Evolus Shareholders Equity (Quarterly): 5.89M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 5.89M |
June 30, 2024 | 19.31M |
March 31, 2024 | 18.44M |
December 31, 2023 | -20.69M |
September 30, 2023 | -19.37M |
June 30, 2023 | -6.963M |
March 31, 2023 | 6.949M |
December 31, 2022 | 18.50M |
September 30, 2022 | 29.22M |
June 30, 2022 | 46.86M |
March 31, 2022 | 67.25M |
December 31, 2021 | 81.88M |
September 30, 2021 | 97.40M |
June 30, 2021 | 106.14M |
March 31, 2021 | 23.29M |
Date | Value |
---|---|
December 31, 2020 | -72.96M |
September 30, 2020 | 35.10M |
June 30, 2020 | 43.60M |
March 31, 2020 | 62.61M |
December 31, 2019 | 79.46M |
September 30, 2019 | 17.04M |
June 30, 2019 | 41.18M |
March 31, 2019 | 75.36M |
December 31, 2018 | 84.38M |
September 30, 2018 | 94.97M |
June 30, 2018 | 37.94M |
March 31, 2018 | 51.98M |
December 31, 2017 | -75.54M |
September 30, 2017 | -15.56M |
December 31, 2016 | -7.106M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-72.96M
Minimum
Dec 2020
106.14M
Maximum
Jun 2021
31.10M
Average
26.25M
Median
Shareholders Equity (Quarterly) Benchmarks
Insulet Corp | 1.118B |
Perspective Therapeutics Inc | 328.47M |
Electromed Inc | 41.49M |
Xtant Medical Holdings Inc | 45.72M |
Myomo Inc | 9.292M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 229.61M |
Total Liabilities (Quarterly) | 223.72M |
Debt to Equity Ratio | 20.58 |
Current Ratio | 2.472 |
Net Debt Paydown Yield | -0.51% |